At a glance
ClinicalIndex Comparison RecordN/ACompleted· 900 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Genetics of Atopic Dermatitis - Eczema Herpeticum
National Institute of Allergy and Infectious Diseases (NIAID)·observational·Posted Aug 13, 2007·Updated Apr 2, 2014
In Brief
An observational study for Atopic Dermatitis. Completed, enrolled 900 participants across 7 sites.
Detailed Summary
People with atopic dermatitis (AD), or eczema, are susceptible to skin infections and inflammations. Some individuals with AD develop a condition known as eczema herpeticum (EH) following exposure to the herpes simplex virus (HSV). The purpose of this study is to identify the genetic determinants that lead people with AD to develop EH and similar conditions caused by other viruses.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtopic Dermatitis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2006
First PostedAug 2007
Primary CompletionJan 2011
TodayJul 2026
First PostedAug 13, 2007
Enrollment StartMay 1, 2006
Primary CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 18.9 years ago